Check pharmacology, toxicology and pharmaceutics papers: citations, claims and retractions

Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1

Gonzalez, F. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Drug-Induced Hepatotoxicity and ProtectionPharmacogenetics and Drug Metabolism

Cited by 555

Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist

Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., et al. (2018) · Science Translational Medicine

Drug Solubulity and Delivery SystemsAdvanced Drug Delivery Systems

Cited by 553

The important role of stratum corneum lipids for the cutaneous barrier function

van Smeden, J., Janssens, M., Gooris, G. S., & Bouwstra, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Advancements in Transdermal Drug DeliveryDermatology and Skin Diseases

Cited by 549

Validation of a common data model for active safety surveillance research

Overhage, J. M., Ryan, P. B., Reich, C. G., Hartzema, A. G., & Stang, P. E. (2012) · Journal of the American Medical Informatics Association

Pharmacovigilance and Adverse Drug ReactionsMedical Coding and Health Information

Cited by 548

Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells

Westerink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro

Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

Cited by 544

The Simcyp ® Population-based ADME Simulator

Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009) · Expert Opinion on Drug Metabolism & Toxicology

Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices

Cited by 533

Delivery of Therapeutic Proteins

Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V. (2010) · Journal of Pharmaceutical Sciences

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 532

Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption

Schmook, F. P., Meingassner, J. G., & Billich, A. (2001) · International Journal of Pharmaceutics

Advancements in Transdermal Drug DeliveryContact Dermatitis and Allergies

Cited by 529

Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats

DeSesso, J. M., & Jacobson, C. F. (2001) · Food and Chemical Toxicology

Drug Solubulity and Delivery SystemsGastrointestinal motility and disorders

Cited by 528

Acute liver necrosis following overdose of paracetamol

Davidson, D. G., & Eastham, W. N. (1966) · BMJ

Drug-Induced Hepatotoxicity and ProtectionPoisoning and overdose treatments

Cited by 528

Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury

Hanawa, N., Shinohara, M., Saberi, B., Gaarde, W. A., Han, D., & Kaplowitz, N. (2008) · Journal of Biological Chemistry

Drug-Induced Hepatotoxicity and ProtectionMitochondrial Function and Pathology

Cited by 527

Detection times of drugs of abuse in blood, urine, and oral fluid

Verstraete, A. G. (2004) · Therapeutic Drug Monitoring

Forensic Toxicology and Drug AnalysisSubstance Abuse Treatment and Outcomes

Cited by 521

Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis

Hein, D. W. (2002) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Pharmacogenetics and Drug MetabolismCarcinogens and Genotoxicity Assessment

Cited by 518

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6

Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., Satoh, S., Niwa, M., Senoh, H., & Fujiwara, H. (1994) · The Journal of Experimental Medicine

Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology

Cited by 517

Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010

Califf, R. M. (2012) · JAMA

Pharmaceutical industry and healthcareStatistical Methods in Clinical Trials

Cited by 516

Is the oral route possible for peptide and protein drug delivery?

Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today

Advanced Drug Delivery SystemsDrug Solubulity and Delivery Systems

Cited by 515

Reproducing human and cross-species drug toxicities using a liver-chip

Jang, K.-J., Otieno, M. A., Ronxhi, J., Lim, H.-K., Ewart, L., Kodella, K. R., Petropolis, D. B., Kulkarni, G., Rubins, J. E., Conegliano, D., et al. (2019) · Science Translational Medicine

Drug-Induced Hepatotoxicity and Protection3D Printing in Biomedical Research

Cited by 511

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions

Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics

Drug-Induced Hepatotoxicity and ProtectionDrug Transport and Resistance Mechanisms

Cited by 509

Effects of the Antifungal Agents on Oxidative Drug Metabolism: Clinical Relevance

Venkatakrishnan, K., von Moltke, L. L., & Greenblatt, D. J. (2000) · Clinical Pharmacokinetics

Pharmacogenetics and Drug MetabolismAntifungal resistance and susceptibility

Cited by 508

Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa

Lamprecht, A., Schäfer, U., & Lehr, C.-M. (2001) · Pharmaceutical Research

Advanced Drug Delivery SystemsNanoparticle-Based Drug Delivery

Cited by 507

Human cytochromes P450 in health and disease

Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences

Pharmacogenetics and Drug MetabolismEicosanoids and Hypertension Pharmacology

Cited by 505

Clinical pharmacokinetics of tyrosine kinase inhibitors

van Erp, N. P., Gelderblom, H., & Guchelaar, H.-J. (2009) · Cancer Treatment Reviews

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 503

Coverage by the news media of the benefits and risks of medications

Moynihan, R., Bero, L., Ross-Degnan, D., Henry, D., Lee, K., Watkins, J., Mah, C., & Soumerai, S. B. (2000) · New England Journal of Medicine

Pharmaceutical industry and healthcareJournalism and Media Studies

Cited by 500

The Vaccine Adverse Event Reporting System (VAERS)

CHEN, R., RASTOGI, S., MULLEN, J., HAYES, S., COCHI, S., DONLON, J., & WASSILAK, S. (1994) · Vaccine

Pharmacovigilance and Adverse Drug ReactionsData-Driven Disease Surveillance

Cited by 498